Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Influence of Gender and Coagulation Factors on Efficacy and Safety of Rivaroxaban in Adolescents & Young Adults with Venous Thromboembolism

Manuela Krause, MD, Verena Limperger, MD, Anna Henningsen, Hartmut Clausnizer, Gili Kenet, MD, Dorothee Kowalski, Ulrike Nowak-Gottl, MD

Blood (2015) 126 (23): 4729.

https://doi.org/10.1182/blood.V126.23.4729.4729

Published: 2015

Journal Articles

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Joerg Kahle, PhD, Aleksander Orlowski, Anja Schmidt, PhD, Kerstin Brettschneider, Thomas Klingebiel, MD, John F Healey, BS, Ernest T Parker, BA, John (Pete) S Lollar, MD, Marc Jacquemin, MD, Manuela Krause, MD, Andreas Tiede, MD PhD, Dirk Schwabe, MD, Christoph Königs, MD PhD

Blood (2015) 126 (23): 3491.

https://doi.org/10.1182/blood.V126.23.3491.3491

Published: 2015

Journal Articles

Efficacy and Safety of Rivaroxaban: An Observationalmulticenter Cohort Study Reporting the Routine Use in Adolescents & Adults with DVT

Manuela Krause, MD, Alexander Bauer, Hartmut Clausnizer, Gili Kenet, MD, Dorothee Kowalski, Verena Limperger, Ann-Kathrin Pilgrimm-Thorp, Daniela Manner, MD, Ulrike Nowak-Göttl, Prof.

Blood (2014) 124 (21): 5083.

https://doi.org/10.1182/blood.V124.21.5083.5083

Published: 2014

Journal Articles

Anti-FVIII Autoantibodies Share Similar Characteristics In Acquired Hemophilia A Patients With and Without An Associated Disease

Joerg Kahle, PhD, Christoph Königs, MD, PhD, Anja Naumann, Thomas Klingebiel, MD, John F Healey, Ernest T Parker, B.A., Pete Lollar, MD, Dirk Schwabe, MD, Manuela Krause, MD

Blood (2013) 122 (21): 1110.

https://doi.org/10.1182/blood.V122.21.1110.1110

Published: 2013

Journal Articles

Therapeutic Algorithm for Patients with Acquired Von Willebrand Syndrome and Monoclonal Gammopathy.

Peter Staritz, MD, Manuela Krause, MD, Rainer Zimmermann, MD, Angela Huth-Kuehne, MD

Blood (2009) 114 (22): 4445.

https://doi.org/10.1182/blood.V114.22.4445.4445

Published: 2009

Journal Articles

Cardiovascular Interventions in Patients with Hemophilia and Severe Von Willebrand Disease.

Andreas Tiede, MD, PhD, Sonja R. Alesci, MD, Klamroth, MD, Katharina Holstein, MD, Manuela Krause, MD, Ronald Fischer, MD, Ute Scholz, MD, Johannes Oldenburg, MD, Silvia Horneff, MD

Blood (2008) 112 (11): 2281.

https://doi.org/10.1182/blood.V112.11.2281.2281

Published: 2008

Journal Articles

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Vytautas Ivaskevicius, MD, Hannelore Rott, MD, Inge Scharrer, MD, PhD, Manuela Krause, MD, Erhard Seifried, MD, PhD, Johannes Oldenburg, MD, PhD

Blood (2007) 110 (11): 2150.

https://doi.org/10.1182/blood.V110.11.2150.2150

Published: 2007

Journal Articles

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Manuela Krause, MD, Christoph Koenigs, MD, Christoph Kessel, Inge Scharrer, MD, Ralf Grossmann, MD, Wolfhard Kreuz, MD

Blood (2006) 108 (11): 1044.

https://doi.org/10.1182/blood.V108.11.1044.1044

Published: 2006

Journal Articles

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

Charis von Auer, MD, Sandra Heinsdorf, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer, MD

Blood (2006) 108 (11): 4056.

https://doi.org/10.1182/blood.V108.11.4056.4056

Published: 2006

Journal Articles

Factor VIII Inhibitors in Haemophilia A Patients after Continuous Infusion of Factor VIII Concentrates.

Charis von Auer, MD, Johannes Oldenburg, MD, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer, CI-Study Group in Germany

Blood (2005) 106 (11): 3198.

https://doi.org/10.1182/blood.V106.11.3198.3198

Published: 2005

Journal Articles

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Manuela Krause, MD, Charis von Auer, MD, Andreas Kurth, MD, Martina Boehm, MD, L. Hovy, MD, Inge Scharrer, MD

Blood (2005) 106 (11): 4072.

https://doi.org/10.1182/blood.V106.11.4072.4072

Published: 2005

Journal Articles

Peginterferon Alfa 2a: Treatment Option for Coagulopathy Associated with Vascular Malformation?.

Charis von Auer, MD, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer

Blood (2005) 106 (11): 4104.

https://doi.org/10.1182/blood.V106.11.4104.4104

Published: 2005

Journal Articles

Factor VIII Inhibitors in Haemophilia A Patients Who Are Considered as Previously Treated Patients.

Charis von Auer, MD, Johannes Oldenburg, MD, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer, PTT- Study Group Germany

Blood (2005) 106 (11): 4105.

https://doi.org/10.1182/blood.V106.11.4105.4105

Published: 2005

Journal Articles

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Steffen Bassus, MD, PhD, Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Thomas Scholz, Eng., Carmen Escuriola-Ettinghausen, MD, Annelie Siegemund, MD, Wolfhart Kreuz, MD, Lothar Engelmann, MD, Carl M. Kirchmaier, MD

Blood (2004) 104 (11): 3098.

https://doi.org/10.1182/blood.V104.11.3098.3098

Published: 2004

Journal Articles

Evaluation of ADAMTS-13 Activity and VWF:Ag Levels in Patients with Ischemic Stroke.

Manuela Krause, MD, Martina Boehm, Ingrid Stier-Brueck, Inge Scharrer, MD

Blood (2004) 104 (11): 3507.

https://doi.org/10.1182/blood.V104.11.3507.3507

Published: 2004

Journal Articles

Relevance of Thrombophilic Risk Factors on Clinical Phenotype in Patients with Haemophilia A.

Manuela Krause, MD, Anika Hahn, Ferrial Peyvandi, MD, Inge Scharrer, MD

Blood (2004) 104 (11): 3981.

https://doi.org/10.1182/blood.V104.11.3981.3981

Published: 2004

Journal Articles

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Ulla Stumpf, MD, Andreas Kurth, MD, Steffen Bassus, MD, PhD, Thomas Scholz, Eng., Carl M. Kirchmaier, MD

Blood (2004) 104 (11): 4029.

https://doi.org/10.1182/blood.V104.11.4029.4029

Published: 2004

Journal Articles

The Frequency and the Significance of ADAMTS-13 Neutralising Inhibitors in 62 Patients with Non-Familial Thrombotic Thrombocytopenic Purpura.

Martina Böhm, PhD, Manuela Krause, MD, Charis Von Auer, MD, Wolfgang Miesbach, MD, Inge Scharrer, MD

Blood (2004) 104 (11): 3945.

https://doi.org/10.1182/blood.V104.11.3945.3945

Published: 2004

Journal Articles

Lipoprotein (A) and Further Prothrombotic Risk Factors in Women with Unexplained Recurrent Miscarriage- Results of a Multicenter Case-Control Study.

Ulrike Nowak-Gottl, MD, Barbara Sonntag, MD, Robert Klamroth, MD, Achim Heinecke, MD, Claus Langer, PhD, Inge Scharrer, MD, Robert Greb, MD, Manuela Krause, MD

Blood (2004) 104 (11): 2599.

https://doi.org/10.1182/blood.V104.11.2599.2599

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Influence of Gender and Coagulation Factors on Efficacy and Safety of Rivaroxaban in Adolescents & Young Adults with Venous Thromboembolism

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Efficacy and Safety of Rivaroxaban: An Observationalmulticenter Cohort Study Reporting the Routine Use in Adolescents & Adults with DVT

Anti-FVIII Autoantibodies Share Similar Characteristics In Acquired Hemophilia A Patients With and Without An Associated Disease

Therapeutic Algorithm for Patients with Acquired Von Willebrand Syndrome and Monoclonal Gammopathy.

Cardiovascular Interventions in Patients with Hemophilia and Severe Von Willebrand Disease.

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

Factor VIII Inhibitors in Haemophilia A Patients after Continuous Infusion of Factor VIII Concentrates.

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Peginterferon Alfa 2a: Treatment Option for Coagulopathy Associated with Vascular Malformation?.

Factor VIII Inhibitors in Haemophilia A Patients Who Are Considered as Previously Treated Patients.

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Evaluation of ADAMTS-13 Activity and VWF:Ag Levels in Patients with Ischemic Stroke.

Relevance of Thrombophilic Risk Factors on Clinical Phenotype in Patients with Haemophilia A.

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

The Frequency and the Significance of ADAMTS-13 Neutralising Inhibitors in 62 Patients with Non-Familial Thrombotic Thrombocytopenic Purpura.

Lipoprotein (A) and Further Prothrombotic Risk Factors in Women with Unexplained Recurrent Miscarriage- Results of a Multicenter Case-Control Study.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only